ADHERE-S (NIS Brilique)

Trial Identifier: D5130R00052
Sponsor: AstraZeneca
NCTID:: NCT03444012
Start Date: March 2018
Primary Completion Date: August 2019

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Serbia Belgrade, Serbia
Serbia Kragujevac, Serbia
Serbia Nis, Serbia
Serbia Sremska Kamenica, Serbia